Epidermal growth factor, from gene organization to bedside

Seminars in Cell and Developmental Biology

Volumn 28, Issue , 2014, Pages 2-11

  Zeng, Fenghua ^a   Harris, Raymond C ^a,b  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DEPARTMENT OF VETERANS AFFAIRS   (United States)

Author keywords

Cancer; Cell proliferation; Epidermal growth factor; Expression; Ion transport; Regeneration

Indexed keywords

EPIDERMAL GROWTH FACTOR; MAGNESIUM; EPIDERMAL GROWTH FACTOR RECEPTOR;

ANIMAL MODEL; BIOLOGICAL FUNCTIONS; EMBRYO DEVELOPMENT; GENE OVEREXPRESSION; GENETIC ORGANIZATION; HUMAN; ION TRANSPORT; NEOPLASM; NONHUMAN; PROTEIN EXPRESSION; REVIEW; SODIUM TRANSPORT; TISSUE DISTRIBUTION; TISSUE REGENERATION; TISSUE SPECIFICITY; TRANSGENIC MOUSE; ULCER; WOUND HEALING; ANIMAL; CELL DIFFERENTIATION; EPITHELIUM CELL; GENE EXPRESSION; GENETICS; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; CELL DIFFERENTIATION; EPIDERMAL GROWTH FACTOR; EPITHELIAL CELLS; GENE EXPRESSION; HUMANS; RECEPTOR, EPIDERMAL GROWTH FACTOR; SIGNAL TRANSDUCTION;

EID: 84901287023     PISSN: 10849521     EISSN: 10963634     Source Type: Journal    
DOI: 10.1016/j.semcdb.2014.01.011     Document Type: Review

References (153)

1. Cohen S. Isolation of a mouse submaxillary gland protein accelerating incisor eruption and eyelid opening in the new-born animal. J Biol Chem 1962, 237:1555-1562.
2. Cohen S., Carpenter G. Human epidermal growth factor: isolation and chemical and biological properties. Proc Natl Acad Sci U S A 1975, 72:1317-1321.
3. Gregory H. Isolation and structure of urogastrone and its relationship to epidermal growth factor. Nature 1975, 257:325-327.
4. Harris R.C., Chung E., Coffey R.J. EGF receptor ligands. Exp Cell Res 2003, 284:2-13.
5. Schneider M.R., Wolf E. The epidermal growth factor receptor ligands at a glance. J Cell Physiol 2009, 218:460-466.
6. Massague J., Pandiella A. Membrane-anchored growth factors. Annu Rev Biochem 1993, 62:515-541.
7. Savage C.R., Hash J.H., Cohen S. Epidermal growth factor. Location of disulfide bonds. J Biol Chem 1973, 248:7669-7672.
8. Carpenter G. Receptors for epidermal growth factor and other polypeptide mitogens. Annu Rev Biochem 1987, 56:881-914.
9. Zeineldin R., Hudson L.G. Epithelial cell migration in response to epidermal growth factor. Methods Mol Biol 2006, 327:147-158.
10. Gray A., Dull T.J., Ullrich A. Nucleotide sequence of epidermal growth factor cDNA predicts a 128,000-molecular weight protein precursor. Nature 1983, 303:722-725.
11. Bell G.I., Fong N.M., Stempien M.M., Wormsted M.A., Caput D., Ku L.L., et al. Human epidermal growth factor precursor: cDNA sequence, expression in vitro and gene organization. Nucleic Acids Res 1986, 14:8427-8446.
12. Derynck R., Roberts A.B., Winkler M.E., Chen E.Y., Goeddel D.V. Human transforming growth factor-alpha: precursor structure and expression in E. coli. Cell 1984, 38:287-297.
13. Le Gall S.M., Auger R., Dreux C., Mauduit P. Regulated cell surface pro-EGF ectodomain shedding is a zinc metalloprotease-dependent process. J Biol Chem 2003, 278:45255-45268.
14. Harris R.C. Potential physiologic roles for epidermal growth factor in the kidney. Am J Kidney Dis 1991, 17:627-630.
15. Read L.C., Upton F.M., Francis G.L., Wallace J.C., Dahlenberg G.W., Ballard F.J. Changes in the growth-promoting activity of human milk during lactation. Pediatr Res 1984, 18:133-139.
16. Dvorak B. Milk epidermal growth factor and gut protection. J Pediatr 2010, 156:S31-S35.
17. Nojiri T., Yoshizato T., Fukami T., Obama H., Yagi H., Yotsumoto F., et al. Clinical significance of amphiregulin and epidermal growth factor in colostrum. Arch Gynecol Obstet 2012, 286:643-647.
18. Carpenter G., Cohen S. Epidermal growth factor. Annu Rev Biochem 1979, 48:193-216.
19. Fisher D.A., Salido E.C., Barajas L. Epidermal growth factor and the kidney. Annu Rev Physiol 1989, 51:67-80.
20. Nair R.R., Warner B.B., Warner B.W. Role of epidermal growth factor and other growth factors in the prevention of necrotizing enterocolitis. Semin Perinatol 2008, 32:107-113.
21. Hofmann G.E., Abramowicz J.S. Epidermal growth factor (EGF) concentrations in amniotic fluid and maternal urine during pregnancy. Acta Obstet Gynecol Scand 1990, 69:217-221.
22. Fisher D.A., Lakshmanan J. Metabolism and effects of epidermal growth factor and related growth factors in mammals. Endocr Rev 1990, 11:418-442.
23. Scott J., Patterson S., Rall L., Bell G.I., Crawford R., Penschow J., et al. The structure and biosynthesis of epidermal growth factor precursor. J Cell Sci Suppl 1985, 3:19-28.
24. Byyny R.L., Orth D.N., Cohen S. Radioimmunoassay of epidermal growth factor. Endocrinology 1972, 90:1261-1266.
25. Gresik E.W., Barka T. Immunocytochemical localization of epidermal growth factor during the postnatal development of the submandibular gland of the mouse. Am J Anat 1978, 151:1-9.
26. Byyny R.L., Orth D.N., Cohen S., Doyne E.S. Epidermal growth factor: effects of androgens and adrenergic agents. Endocrinology 1974, 95:776-782.
27. Pointon S.E., Banerjee S.P. Alpha- and beta-adrenergic receptors of the rat salivary gland. Elevation after chemical sympathectomy. Biochim Biophys Acta 1979, 584:231-241.
28. Camprecios G., Navarro M., Soley M., Ramirez I. Acute and chronic adrenergic stimulation of submandibular salivary glands. Effects on the endocrine function of epidermal growth factor in mice. Growth Factors 2009, 27:300-308.
29. Grau M., Rodriguez C., Soley M., Ramirez I. Relationship between epidermal growth factor in mouse submandibular glands, plasma, and bile: effects of catecholamines and fasting. Endocrinology 1994, 135:1854-1862.
30. Hirata Y., Orth D.N. Epidermal growth factor (urogastrone) in human tissues. J Clin Endocrinol Metab 1979, 48:667-672.
31. Sakamoto K., Oka Y., Uda K., Chiba K., Waki Y., Suzuki W., et al. Rat epidermal growth factors: purification and tissue content. Endocrinol Jpn 1989, 36:289-297.
32. Gann P.H., Klein K.G., Chatterton R.T., Ellman A.E., Grayhack J.T., Nadler R.B., et al. Growth factors in expressed prostatic fluid from men with prostate cancer, BPH, and clinically normal prostates. Prostate 1999, 40:248-255.
33. Rall L.B., Scott J., Bell G.I., Crawford R.J., Penschow J.D., Niall H.D., et al. Mouse prepro-epidermal growth factor synthesis by the kidney and other tissues. Nature 1985, 313:228-231.
34. Parries G., Chen K., Misono K.S., Cohen S. The human urinary epidermal growth factor (EGF) precursor. Isolation of a biologically active 160-kilodalton heparin-binding pro-EGF with a truncated carboxyl terminus. J Biol Chem 1995, 270:27954-27960.
35. Mattila A.L. Human urinary epidermal growth factor: effects of age, sex and female endocrine status. Life Sci 1986, 39:1879-1884.
36. Watanabe H. Epidermal growth factor in urine of pregnant women and in amniotic fluid throughout pregnancy. Gynecol Endocrinol 1990, 4:43-50.
37. Okada T., Omoto-Kitao M., Mukamoto M., Nakamura J., Mino M., Kondo T., et al. Compensatory renal growth in uninephrectomized immature rats: proliferative activity and epidermal growth factor. J Vet Med Sci 2010, 72:975-980.
38. Zeng F., Singh A.B., Harris R.C. The role of the EGF family of ligands and receptors in renal development, physiology and pathophysiology. Exp Cell Res 2009, 315:602-610.
39. Staruschenko A., Palygin O., Ilatovskaya D.V., Pavlov T.S. Epidermal growth factors in the kidney and relationship to hypertension. Am J Physiol Renal Physiol 2013, 305:F12-F20.
40. Raaberg L., Nexo E., Damsgaard Mikkelsen J., Seier Poulsen S. Immunohistochemical localisation and developmental aspects of epidermal growth factor in the rat. Histochemistry 1988, 89:351-356.
41. Goodyer P.R., Fata J., Mulligan L., Fischer D., Fagan R., Guyda H.J., et al. Expression of transforming growth factor-alpha and epidermal growth factor receptor in human fetal kidneys. Mol Cell Endocrinol 1991, 77:199-206.
42. Gattone V.H., Sherman D.A., Hinton D.A., Niu F.W., Topham R.T., Klein R.M. Epidermal growth factor in the neonatal mouse salivary gland and kidney. Biol Neonate 1992, 61:54-67.
43. Eda T., Mizuno M., Araki K., Iwakura Y., Namba H., Sotoyama H., et al. Neurobehavioral deficits of epidermal growth factor-overexpressing transgenic mice: impact on dopamine metabolism. Neurosci Lett 2013, 547:21-25.
44. Mak K.K., Chan S.Y. Epidermal growth factor as a biologic switch in hair growth cycle. J Biol Chem 2003, 278:26120-26126.
45. Wong R.W., Kwan R.W., Mak P.H., Mak K.K., Sham M.H., Chan S.Y. Overexpression of epidermal growth factor induced hypospermatogenesis in transgenic mice. J Biol Chem 2000, 275:18297-18301.
46. Clark J.A., Gan H., Samocha A.J., Fox A.C., Buchman T.G., Coopersmith C.M. Enterocyte-specific epidermal growth factor prevents barrier dysfunction and improves mortality in murine peritonitis. Am J Physiol Gastrointest Liver Physiol 2009, 297:G471-G479.
47. Erwin C.R., Helmrath M.A., Shin C.E., Falcone R.A., Stern L.E., Warner B.W. Intestinal overexpression of EGF in transgenic mice enhances adaptation after small bowel resection. Am J Physiol 1999, 277:G533-G540.
48. Troyer K.L., Luetteke N.C., Saxon M.L., Qiu T.H., Xian C.J., Lee D.C. Growth retardation, duodenal lesions, and aberrant ileum architecture in triple null mice lacking EGF, amphiregulin, and TGF-alpha. Gastroenterology 2001, 121:68-78.
49. Chan S.Y., Wong R.W. Expression of epidermal growth factor in transgenic mice causes growth retardation. J Biol Chem 2000, 275:38693-38698.
50. Luetteke N.C., Phillips H.K., Qiu T.H., Copeland N.G., Earp H.S., Jenkins N.A., et al. The mouse waved-2 phenotype results from a point mutation in the EGF receptor tyrosine kinase. Genes Dev 1994, 8:399-413.
51. Shahbazi M., Pravica V., Nasreen N., Fakhoury H., Fryer A.A., Strange R.C., et al. Association between functional polymorphism in EGF gene and malignant melanoma. Lancet 2002, 359:397-401.
52. Dissanayake V.H., Tower C., Broderick A., Stocker L.J., Seneviratne H.R., Jayasekara R.W., et al. Polymorphism in the epidermal growth factor gene is associated with birthweight in Sinhalese and white Western Europeans. Mol Hum Reprod 2007, 13:425-429.
53. Tanabe K.K., Lemoine A., Finkelstein D.M., Kawasaki H., Fujii T., Chung R.T., et al. Epidermal growth factor gene functional polymorphism and the risk of hepatocellular carcinoma in patients with cirrhosis. J Am Med Assoc 2008, 299:53-60.
54. Yang Z., Wu Q., Shi Y., Nie Y., Wu K., Fan D. Epidermal growth factor 61A>G polymorphism is associated with risk of hepatocellular carcinoma: a meta-analysis. Genet Test Mol Biomarkers 2012, 16:1086-1091.
55. Araujo A.P., Ribeiro R., Pereira D., Pinto D., Sousa B., Catarino R., et al. Ovarian cancer and genetic susceptibility: association of A61G polymorphism in the EGF gene. Exp Biol Med (Maywood) 2009, 234:241-245.
56. Li T.F., Ren K.W., Liu P.F. Meta-analysis of epidermal growth factor polymorphisms and cancer risk: involving 9,779 cases and 15,932 controls. DNA Cell Biol 2012, 31:568-574.
57. Luetteke N.C., Qiu T.H., Fenton S.E., Troyer K.L., Riedel R.F., Chang A., et al. Targeted inactivation of the EGF and amphiregulin genes reveals distinct roles for EGF receptor ligands in mouse mammary gland development. Development 1999, 126:2739-2750.
58. Kwan R.W., Wong R.W., Chan S.Y. Expression of full length or truncated epidermal growth factor precursor transforms NIH3T3 fibroblasts. Int J Oncol 1999, 15:281-284.
59. Galvez-Contreras A.Y., Quinones-Hinojosa A., Gonzalez-Perez O. The role of EGFR and ErbB family related proteins in the oligodendrocyte specification in germinal niches of the adult mammalian brain. Front Cell Neurosci 2013, 7:258.
60. Chong C.R., Janne P.A. The quest to overcome resistance to EGFR-targeted therapies in cancer. Nat Med 2013, 19:1389-1400.
61. Carpenter G., Cohen S. Epidermal growth factor. J Biol Chem 1990, 265:7709-7712.
62. Wei Z., Park K.W., Day B.N., Prather R.S. Effect of epidermal growth factor on preimplantation development and its receptor expression in porcine embryos. Mol Reprod Dev 2001, 60:457-462.
63. Dadi T.D., Li M.W., Lloyd K.C. EGF and TGF-alpha supplementation enhances development of cloned mouse embryos. Cloning Stem Cells 2007, 9:315-326.
64. Schultz G.A., Heyner S. Growth factors in preimplantation mammalian embryos. Oxf Rev Reprod Biol 1993, 15:43-81.
65. Paria B.C., Dey S.K. Preimplantation embryo development in vitro: cooperative interactions among embryos and role of growth factors. Proc Natl Acad Sci U S A 1990, 87:4756-4760.
66. Grazul-Bilska A.T., Choi J.T., Bilski J.J., Weigl R.M., Kirsch J.D., Kraft K.C., et al. Effects of epidermal growth factor on early embryonic development after in vitro fertilization of oocytes collected from ewes treated with follicle stimulating hormone. Theriogenology 2003, 59:1449-1457.
67. Nielsen L.L., Werb Z., Pedersen R.A. Induction of c-fos transcripts in early postimplantation mouse embryos by TGF-alpha, EGF, PDGF, and FGF. Mol Reprod Dev 1991, 29:227-237.
68. Haimovici F., Anderson D.J. Effects of growth factors and growth factor-extracellular matrix interactions on mouse trophoblast outgrowth in vitro. Biol Reprod 1993, 49:124-130.
69. Kamei Y., Tsutsumi O., Yamakawa A., Oka Y., Taketani Y., Imaki J. Maternal epidermal growth factor deficiency causes fetal hypoglycemia and intrauterine growth retardation in mice: possible involvement of placental glucose transporter GLUT3 expression. Endocrinology 1999, 140:4236-4243.
70. Martinez-Hernandez M.G., Baiza-Gutman L.A., Castillo-Trapala A., Armant D.R. Regulation of proteinases during mouse peri-implantation development: urokinase-type plasminogen activator expression and cross talk with matrix metalloproteinase 9. Reproduction 2011, 141:227-239.
71. Aflalo E.D., Sod-Moriah U.A., Potashnik G., Har-Vardi I. EGF increases expression and activity of PAs in preimplantation rat embryos and their implantation rate. Reprod Biol Endocrinol 2007, 5:4.
72. Huarte J., Belin D., Vassalli J.D. Plasminogen activator in mouse and rat oocytes: induction during meiotic maturation. Cell 1985, 43:551-558.
73. Tsafriri A., Bicsak T.A., Cajander S.B., Ny T., Hsueh A.J. Suppression of ovulation rate by antibodies to tissue-type plasminogen activator and alpha 2-antiplasmin. Endocrinology 1989, 124:415-421.
74. Huarte J., Vassalli J.D., Belin D., Sakkas D. Involvement of the plasminogen activator/plasmin proteolytic cascade in fertilization. Dev Biol 1993, 157:539-546.
75. Sappino A.P., Huarte J., Belin D., Vassalli J.D. Plasminogen activators in tissue remodeling and invasion: mRNA localization in mouse ovaries and implanting embryos. J Cell Biol 1989, 109:2471-2479.
76. Wiley L.M., Wu J.X., Harari I., Adamson E.D. Epidermal growth factor receptor mRNA and protein increase after the four-cell preimplantation stage in murine development. Dev Biol 1992, 149:247-260.
77. Dackor J., Strunk K.E., Wehmeyer M.M., Threadgill D.W. Altered trophoblast proliferation is insufficient to account for placental dysfunction in Egfr null embryos. Placenta 2007, 28:1211-1218.
78. Dackor J., Caron K.M., Threadgill D.W. Placental and embryonic growth restriction in mice with reduced function epidermal growth factor receptor alleles. Genetics 2009, 183:207-218.
79. Threadgill D.W., Dlugosz A.A., Hansen L.A., Tennenbaum T., Lichti U., Yee D., et al. Targeted disruption of mouse EGF receptor: effect of genetic background on mutant phenotype. Science 1995, 269:230-234.
80. Dackor J., Li M., Threadgill D.W. Placental overgrowth and fertility defects in mice with a hypermorphic allele of epidermal growth factor receptor. Mamm Genome 2009, 20:339-349.
81. Lindvall O., Kokaia Z. Stem cells in human neurodegenerative disorders - time for clinical translation?. J Clin Invest 2010, 120:29-40.
82. Li L., Clevers H. Coexistence of quiescent and active adult stem cells in mammals. Science 2010, 327:542-545.
83. Strand M., Micchelli C.A. Regional control of drosophila gut stem cell proliferation: EGF establishes GSSC proliferative set point & controls emergence from quiescence. PLoS One 2013, 8:e80608.
84. Medema J.P., Vermeulen L. Microenvironmental regulation of stem cells in intestinal homeostasis and cancer. Nature 2011, 474:318-326.
85. Fuchs E., Tumbar T., Guasch G. Socializing with the neighbors: stem cells and their niche. Cell 2004, 116:769-778.
86. Watt F.M., Hogan B.L. Out of Eden: stem cells and their niches. Science 2000, 287:1427-1430.
87. Aghila Rani K.G., Kartha C.C. Effects of epidermal growth factor on proliferation and migration of cardiosphere-derived cells expanded from adult human heart. Growth Factors 2010, 28:157-165.
88. Nelson A.D., Suzuki M., Svendsen C.N. A high concentration of epidermal growth factor increases the growth and survival of neurogenic radial glial cells within human neurosphere cultures. Stem Cells 2008, 26:348-355.
89. Suzuki Y., Yanagisawa M., Yagi H., Nakatani Y., Yu R.K. Involvement of beta1-integrin up-regulation in basic fibroblast growth factor- and epidermal growth factor-induced proliferation of mouse neuroepithelial cells. J Biol Chem 2010, 285:18443-18451.
90. Garcez R.C., Teixeira B.L., Schmitt Sdos S., Alvarez-Silva M., Trentin A.G. Epidermal growth factor (EGF) promotes the in vitro differentiation of neural crest cells to neurons and melanocytes. Cell Mol Neurobiol 2009, 29:1087-1091.
91. Parrott B.B., Hudson A., Brady R., Schulz C. Control of germline stem cell division frequency - a novel, developmentally regulated role for epidermal growth factor signaling. PLoS One 2012, 7:e36460.
92. Tamama K., Kawasaki H., Wells A. Epidermal growth factor (EGF) treatment on multipotential stromal cells (MSCs). Possible enhancement of therapeutic potential of MSC. J Biomed Biotechnol 2010, 2010:795385.
93. Soeda A., Inagaki A., Oka N., Ikegame Y., Aoki H., Yoshimura S., et al. Epidermal growth factor plays a crucial role in mitogenic regulation of human brain tumor stem cells. J Biol Chem 2008, 283:10958-10966.
94. Park J.H., Han H.J. Caveolin-1 plays important role in EGF-induced migration and proliferation of mouse embryonic stem cells: involvement of PI3K/Akt and ERK. Am J Physiol Cell Physiol 2009, 297:C935-C944.
95. Suzuki A., Sekiya S., Gunshima E., Fujii S., Taniguchi H. EGF signaling activates proliferation and blocks apoptosis of mouse and human intestinal stem/progenitor cells in long-term monolayer cell culture. Lab Invest 2010, 90:1425-1436.
96. Nanba D., Toki F., Barrandon Y., Higashiyama S. Recent advances in the epidermal growth factor receptor/ligand system biology on skin homeostasis and keratinocyte stem cell regulation. J Dermatol Sci 2013, 72:81-86.
97. Belmadani S., Matrougui K., Kolz C., Pung Y.F., Palen D., Prockop D.J., et al. Amplification of coronary arteriogenic capacity of multipotent stromal cells by epidermal growth factor. Arterioscler Thromb Vasc Biol 2009, 29:802-808.
98. Kuhl P.R., Griffith-Cima L.G. Tethered epidermal growth factor as a paradigm for growth factor-induced stimulation from the solid phase. Nat Med 1996, 2:1022-1027.
99. Fan V.H., Tamama K., Au A., Littrell R., Richardson L.B., Wright J.W., et al. Tethered epidermal growth factor provides a survival advantage to mesenchymal stem cells. Stem Cells 2007, 25:1241-1251.
100. Kerpedjieva S.S., Kim D.S., Barbeau D.J., Tamama K. EGFR ligands drive multipotential stromal cells to produce multiple growth factors and cytokines via early growth response-1. Stem Cells Dev 2012, 21:2541-2551.
101. Zheleznova N.N., Wilson P.D., Staruschenko A. Epidermal growth factor-mediated proliferation and sodium transport in normal and PKD epithelial cells. Biochim Biophys Acta 2011, 1812:1301-1313.
102. O'Mahony F., Toumi F., Mroz M.S., Ferguson G., Keely S.J. Induction of Na+/K+/2Cl- cotransporter expression mediates chronic potentiation of intestinal epithelial Cl- secretion by EGF. Am J Physiol Cell Physiol 2008, 294:C1362-C1370.
103. Mroz M.S., Keely S.J. Epidermal growth factor chronically upregulates Ca(2+)-dependent Cl(-) conductance and TMEM16A expression in intestinal epithelial cells. J Physiol 2012, 590:1907-1920.
104. Trinh N.T., Prive A., Maille E., Noel J., Brochiero E. EGF and K+ channel activity control normal and cystic fibrosis bronchial epithelia repair. Am J Physiol Lung Cell Mol Physiol 2008, 295:L866-L880.
105. Bezzerides V.J., Ramsey I.S., Kotecha S., Greka A., Clapham D.E. Rapid vesicular translocation and insertion of TRP channels. Nat Cell Biol 2004, 6:709-720.
106. Pavlov T.S., Levchenko V., O'Connor P.M., Ilatovskaya D.V., Palygin O., Mori T., et al. Deficiency of renal cortical EGF increases ENaC activity and contributes to salt-sensitive hypertension. J Am Soc Nephrol 2013, 24:1053-1062.
107. Veizis I.E., Cotton C.U. Abnormal EGF-dependent regulation of sodium absorption in ARPKD collecting duct cells. Am J Physiol Renal Physiol 2005, 288:F474-F482.
108. Cao L., Owsianik G., Becq F., Nilius B. Chronic exposure to EGF affects trafficking and function of ENaC channel in cystic fibrosis cells. Biochem Biophys Res Commun 2005, 331:503-511.
109. Danto S.I., Borok Z., Zhang X.L., Lopez M.Z., Patel P., Crandall E.D., et al. Mechanisms of EGF-induced stimulation of sodium reabsorption by alveolar epithelial cells. Am J Physiol 1998, 275:C82-C92.
110. Khurana S., Nath S.K., Levine S.A., Bowser J.M., Tse C.M., Cohen M.E., et al. Brush border phosphatidylinositol 3-kinase mediates epidermal growth factor stimulation of intestinal NaCl absorption and Na+/H+ exchange. J Biol Chem 1996, 271:9919-9927.
111. Vehaskari V.M., Herndon J., Hamm L.L. Mechanism of sodium transport inhibition by epidermal growth factor in cortical collecting ducts. Am J Physiol 1991, 261:F896-F903.
112. Vehaskari V.M., Hering-Smith K.S., Moskowitz D.W., Weiner I.D., Hamm L.L. Effect of epidermal growth factor on sodium transport in the cortical collecting tubule. Am J Physiol 1989, 256:F803-F809.
113. Poulsen S.S., Nexo E., Olsen P.S., Hess J., Kirkegaard P. Immunohistochemical localization of epidermal growth factor in rat and man. Histochemistry 1986, 85:389-394.
114. Levchenko V., Zheleznova N.N., Pavlov T.S., Vandewalle A., Wilson P.D., Staruschenko A. EGF and its related growth factors mediate sodium transport in mpkCCDc14 cells via ErbB2 (neu/HER-2) receptor. J Cell Physiol 2010, 223:252-259.
115. Muallem S., Moe O.W., When E.G.F. is offside, magnesium is wasted. J Clin Invest 2007, 117:2086-2089.
116. Groenestege W.M., Thebault S., van der Wijst J., van den Berg D., Janssen R., Tejpar S., et al. Impaired basolateral sorting of pro-EGF causes isolated recessive renal hypomagnesemia. J Clin Invest 2007, 117:2260-2267.
117. Ledeganck K.J., Boulet G.A., Bogers J.J., Verpooten G.A., De Winter B.Y. The TRPM6/EGF pathway is downregulated in a rat model of cisplatin nephrotoxicity. PLoS One 2013, 8:e57016.
118. Quamme G.A., Dirks J.H. Intraluminal and contraluminal magnesium on magnesium and calcium transfer in the rat nephron. Am J Physiol 1980, 238:F187-F198.
119. 2+ absorption. J Biol Chem 2004, 279:19-25.
120. Thebault S., Alexander R.T., Tiel Groenestege W.M., Hoenderop J.G., Bindels R.J. EGF increases TRPM6 activity and surface expression. J Am Soc Nephrol 2009, 20:78-85.
121. Dimke H., van der Wijst J., Alexander T.R., Meijer I.M., Mulder G.M., van Goor H., et al. Effects of the EGFR inhibitor erlotinib on magnesium handling. J Am Soc Nephrol 2010, 21:1309-1316.
122. Tejpar S., Piessevaux H., Claes K., Piront P., Hoenderop J.G., Verslype C., et al. Magnesium wasting associated with epidermal-growth-factor receptor-targeting antibodies in colorectal cancer: a prospective study. Lancet Oncol 2007, 8:387-394.
123. Ledeganck K.J., Boulet G.A., Horvath C.A., Vinckx M., Bogers J.J., Van Den Bossche R., et al. Expression of renal distal tubule transporters TRPM6 and NCC in a rat model of cyclosporine nephrotoxicity and effect of EGF treatment. Am J Physiol Renal Physiol 2011, 301. F486-93.
124. Mimura Y., Ihn H., Jinnin M., Asano Y., Yamane K., Tamaki K. Epidermal growth factor affects the synthesis and degradation of type I collagen in cultured human dermal fibroblasts. Matrix Biol 2006, 25:202-212.
125. Marquez E.B., De Ortueta D., Royo S.B., Martinez-Carpio P.A. Epidermal growth factor receptor in corneal damage: update and new insights from recent reports. Cutan Ocul Toxicol 2011, 30:7-14.
126. Hardwicke J., Schmaljohann D., Boyce D., Thomas D. Epidermal growth factor therapy and wound healing - past, present and future perspectives. Surgeon 2008, 6:172-177.
127. Tiaka E.K., Papanas N., Manolakis A.C., Georgiadis G.S. Epidermal growth factor in the treatment of diabetic foot ulcers: an update. Perspect Vasc Surg Endovasc Ther 2012, 24:37-44.
128. Arda-Pirincci P., Bolkent S. The role of epidermal growth factor in prevention of oxidative injury and apoptosis induced by intestinal ischemia/reperfusion in rats. Acta Histochem 2014, 116:167-175.
129. Lorita J., Soley M., Ramirez I. Epidermal growth factor protects the heart against low-flow ischemia-induced injury. J Physiol Biochem 2010, 66:55-62.
130. Hussein Ael A., Shokeir A.A., Sarhan M.E., El-Menabawy F.R., Abd-Elmoneim H.A., El-Nashar E.M., et al. Effects of combined erythropoietin and epidermal growth factor on renal ischaemia/reperfusion injury: a randomized experimental controlled study. BJU Int 2011, 107:323-328.
131. Barrientos S., Stojadinovic O., Golinko M.S., Brem H., Tomic-Canic M. Growth factors and cytokines in wound healing. Wound Repair Regen 2008, 16:585-601.
132. Chen R.R., Mooney D.J. Polymeric growth factor delivery strategies for tissue engineering. Pharm Res 2003, 20:1103-1112.
133. Brown G.L., Nanney L.B., Griffen J., Cramer A.B., Yancey J.M., Curtsinger L.J., et al. Enhancement of wound healing by topical treatment with epidermal growth factor. N Engl J Med 1989, 321:76-79.
134. Xie Y., Upton Z., Richards S., Rizzi S.C., Leavesley D.I. Hyaluronic acid: evaluation as a potential delivery vehicle for vitronectin:growth factor complexes in wound healing applications. J Control Release 2011, 153:225-232.
135. Ulubayram K., Nur Cakar A., Korkusuz P., Ertan C., Hasirci N. EGF containing gelatin-based wound dressings. Biomaterials 2001, 22:1345-1356.
136. Choi J.S., Leong K.W., Yoo H.S. In vivo wound healing of diabetic ulcers using electrospun nanofibers immobilized with human epidermal growth factor (EGF). Biomaterials 2008, 29:587-596.
137. Alemdaroglu C., Degim Z., Celebi N., Zor F., Ozturk S., Erdogan D. An investigation on burn wound healing in rats with chitosan gel formulation containing epidermal growth factor. Burns 2006, 32:319-327.
138. Yang C.H. Evaluation of the release rate of bioactive recombinant human epidermal growth factor from crosslinking collagen sponges. J Mater Sci Mater Med 2008, 19:1433-1440.
139. Lee J.H., Bae I.H., Choi J.K., Park J.W. Evaluation of a highly skin permeable low-molecular-weight protamine conjugated epidermal growth factor for novel burn wound healing therapy. J Pharm Sci 2013, 102:4109-4120.
140. Marquez L., de Abreu F.A., Ferreira C.L., Alves G.D., Miziara M.N., Alves J.B. Enhanced bone healing of rat tooth sockets after administration of epidermal growth factor (EGF) carried by liposome. Injury 2013, 44:558-564.
141. Berlanga-Acosta J., Gavilondo-Cowley J., Lopez-Saura P., Gonzalez-Lopez T., Castro-Santana M.D., Lopez-Mola E., et al. Epidermal growth factor in clinical practice - a review of its biological actions, clinical indications and safety implications. Int Wound J 2009, 6:331-346.
142. Fernandez-Montequin J.I., Valenzuela-Silva C.M., Diaz O.G., Savigne W., Sancho-Soutelo N., Rivero-Fernandez F., et al. Intra-lesional injections of recombinant human epidermal growth factor promote granulation and healing in advanced diabetic foot ulcers: multicenter, randomised, placebo-controlled, double-blind study. Int Wound J 2009, 6:432-443.
143. Sari Kilicaslan S.M., Coskun Cevher S., Gulec Peker E.G. Ultrastructural changes in blood vessels in epidermal growth factor treated experimental cutaneous wound model. Pathol Res Pract 2013, 209:710-715.
144. Gomez G.G., Wykosky J., Zanca C., Furnari F.B., Cavenee W.K. Therapeutic resistance in cancer: microRNA regulation of EGFR signaling networks. Cancer Biol Med 2013, 10:192-205.
145. De Jong K.P., Stellema R., Karrenbeld A., Koudstaal J., Gouw A.S., Sluiter W.J., et al. Clinical relevance of transforming growth factor alpha, epidermal growth factor receptor, p53, and Ki67 in colorectal liver metastases and corresponding primary tumors. Hepatology 1998, 28:971-979.
146. Lo H.W., Hung M.C., Nuclear E.G.F.R. signalling network in cancers: linking EGFR pathway to cell cycle progression, nitric oxide pathway and patient survival. Br J Cancer 2006, 94:184-188.
147. Bracher A., Cardona A.S., Tauber S., Fink A.M., Steiner A., Pehamberger H., et al. Epidermal growth factor facilitates melanoma lymph node metastasis by influencing tumor lymphangiogenesis. J Invest Dermatol 2013, 133:230-238.
148. Wang S.C., Hung M.C. Nuclear translocation of the epidermal growth factor receptor family membrane tyrosine kinase receptors. Clin Cancer Res 2009, 15:6484-6489.
149. Jutten B., Rouschop K.M. EGFR signaling and autophagy dependence for growth, survival, and therapy resistance. Cell Cycle 2014, 13:42-51.
150. Wei Y., Zou Z., Becker N., Anderson M., Sumpter R., Xiao G., et al. EGFR-mediated Beclin 1 phosphorylation in autophagy suppression, tumor progression, and tumor chemoresistance. Cell 2013, 154:1269-1284.
151. Avraham R., Sas-Chen A., Manor O., Steinfeld I., Shalgi R., Tarcic G., et al. EGF decreases the abundance of microRNAs that restrain oncogenic transcription factors. Sci Signal 2010, 3:ra43.
152. Del Vecchio C.A., Li G., Wong A.J. Targeting EGF receptor variant III: tumor-specific peptide vaccination for malignant gliomas. Expert Rev Vaccines 2012, 11:133-144.
153. Yewale C., Baradia D., Vhora I., Patil S., Misra A. Epidermal growth factor receptor targeting in cancer: a review of trends and strategies. Biomaterials 2013, 34:8690-8707.